Compugen (CGEN) Other Non-Current Assets (2009 - 2026)
Compugen's (CGEN) quarterly Other Non-Current Assets came in at $1.3 million in Q1 2026, down 20.84% year-on-year from $1.6 million in Q1 2025, and little changed quarter-over-quarter from $1.3 million in Q4 2025.
Compugen (CGEN) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Compugen has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $1.3 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.3 million, down 20.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 20.84% YoY), and the FY2025 annual result was $1.3 million, down 31.51% from the prior year.
- Other Non-Current Assets came in at $1.3 million for Q1 2026 at Compugen, roughly flat from $1.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.9 million in Q1 2022 to a low of $362000.0 in Q4 2022.
- The 5-year median for Other Non-Current Assets is $1.5 million (2025), against an average of $1.3 million.
- Peak annual rise in Other Non-Current Assets reached 417.26% in 2024, while the deepest fall reached 51.05% in 2024.
- Compugen's Other Non-Current Assets stood at $362000.0 in 2022, then rose by 0.83% to $365000.0 in 2023, then jumped by 417.26% to $1.9 million in 2024, then slumped by 31.51% to $1.3 million in 2025, then rose by 0.15% to $1.3 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 365,000.00 |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 615,000.00 |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 362,000.00 |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 363,000.00 |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 713,000.00 |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 681,000.00 |
| Mar 31, 2021 | 1.88 Mn |